Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia

Keywords

Stromal cell, Cancer research, Biology, Downregulation and upregulation, KRAS

References

• The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targetingMartha Holman, Lamar Gailey — 2010
• Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor SuppressorJean‐Philippe Coppé, Christopher K Patil, Francis Rodier — 2008
• Pancreatic duct epithelial cell isolation and cultivation in two-dimensional and three-dimensional culture systems.Cristina Agbunag, Kyoung Eun Lee, Serena Buontempo — 2006
• Transcriptional regulation of mouse granulocyte-macrophage colony-stimulating factor/IL-3 locus.Cameron S. Osborne, M A Vadas, Peter N. Cockerill — 1995
• A ras-Mutated Peptide Targeted by CTL Infiltrating a Human Melanoma Lesion1Boris Linard, Stéphane Bezieau, Houssem Benlalam — 2002
• Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation.Vincenzo Bronte, Dale B. Chappell, Elisa Apolloni — 1999
• Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradicationSergio A. Quezada, Karl S. Peggs, Tyler R. Simpson — 2011
• Molecular Signatures of Pancreatic CancerSeung‐Mo Hong, Jason Y. Park, Ralph H. Hruban — 2011
• Murine Pancreatic Adenocarcinoma Dampens SHIP-1 Expression and Alters MDSC Homeostasis and FunctionShari Pilon‐Thomas, Nadine Nelson, Nasreen A. Vohra — 2011
• RAS oncogenes: weaving a tumorigenic webYuliya Pylayeva‐Gupta, Elda Grabocka, Dafna Bar‐Sagi — 2011
• Hematopoietic cytokines in the sera of patients with pancreatic cancerBarbara Mroczko, Maciej Szmitkowski, Urszula Wereszczyńska-Siemiątkowska — 2005
• Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.Carolyn E. Clark, Gregory L. Beatty, Robert H. Vonderheide — 2009
• GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b−Gr1− bone marrow progenitor cells into myeloid-derived suppressor cellsJohanna K. Morales, Maciej Kmieciak, Keith L. Knutson — 2009
• Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.Sunil R. Hingorani, Lifu Wang, Asha S. Multani — 2005
• The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitorsYoshiya Kawaguchi, Bonnie Cooper, Maureen Gannon — 2002
• Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.Erica L. Jackson, Nicholas A. Willis, Kim L. Mercer — 2001
• Myeloid-derived-suppressor cells as regulators of the immune systemDmitry I. Gabrilovich, Srinivas Nagaraj — 2009
• Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity.Cecilia Melani, Claudia Chiodoni, Guido Forni — 2003
• Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detectionChanjuan Shi, Noriyoshi Fukushima, Tadayoshi Abe — 2008
• Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSFLuigi Dolcetti, Elisa Peranzoni, Stefano Ugel — 2009

Cited by

• Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer清隆 植田 — 2014
• RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.H. S. McLean, B.I. Cohen, D. D. Ryutov — 2015
• Macrophages: Biology and Role in the Pathology of DiseasesSubhra K. Biswas, Alberto Mantovani — 2014
• Pancreatic Inflammation and CarcinogenesisConstantinos P. Zambirinis and George Miller — 2015
• Chronic Traumatic Encephalopathy: The Neuropathological Legacy of Traumatic Brain InjuryJennifer Hay, Victoria E. Johnson, Douglas H. Smith — 2016
• Control of CD8 T-cell Infiltration into Tumors by Vasculature and MicroenvironmentJ. David Peske, Amber B. Woods, Víctor H. Engelhard — 2015
• Stress Response Pathways in CancerGeorg T. Wondrak — 2015
• State of the art and future directions of pancreatic ductal adenocarcinoma therapy.Cindy Neuzillet, Annemilaï Tijeras‐Raballand, Philippe Bourget — 2015
• Perspectives in the treatment of pancreatic adenocarcinoma.Ángel Cid-Arregui — 2015
• Induction of T cell immunity overcomes resistance to PD-1 and CTLA-4 blockade and improves survival in pancreatic cancerRafael Winograd — 2015
• Immune cells in pancreatic cancerYaqing Zhang, Florencia McAllister, Marina Pasca di Magliano — 2014
• Obesity accelerates Helicobacter felis-induced gastric carcinogenesis by enhancing immature myeloid cell trafficking and TH17 responseRussell Ericksen, Shannon E. Rose, C. Benedikt Westphalen — 2013
• Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer.Shintaro Takeuchi, Muhammad Baghdadi, Takahiro Tsuchikawa — 2015
• The role of Mnk1 kinase in pancreas biology and exocrine diseasesJ. Cendrowski — 2013
• TLR9 ligation in pancreatic stellate cells promotes tumorigenesisConstantinos P. Zambirinis, Elliot Levie, Susanna Nguy — 2015
• Emerging cytokine networks in colorectal cancerNathaniel R. West, Sarah McCuaig, Fanny Franchini — 2015
• The role of CD4[superscript +]T cells during adoptive and active-specific cancer immunotherapyS. Church — 2012
• Epigenetic and Immune Regulation of Colorectal Cancer Stem CellsAmy V. Paschall, Kebin Liu — 2015
• Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted NanovesiclesVictor Blanco, Tahir Latif, Zhengtao Chu — 2015
• TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesisJesse Gore, Kelly E. Craven, Julie L. Wilson — 2015

Related papers

• Assessing the significance of KRAS G12C mutation: Clinicopathologic features, treatments, and survival outcomes in a real-world KRAS mutant non-small cell lung cancer cohort.Wanyuan Cui, Fanny Franchini, Marliese Alexander — 2020
• Lung Cancer and KRAS -Its Molecular Biology/Genetics and Therapeutic Strategy-T. Koga, Tetsuya Mitsudomi — 2022
• Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancerLuiz H. Araujo, Bianca Marmontel de Souza, Laura Hora Rios Leite — 2020
• 127P RAS, RAF and NF1 oncogenic mutations in KRAS-mutated lung adenocarcinomaDaniele Marinelli, Simona Pisegna, Antonella Chiavassa — 2022
• Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancerLuiz H. Araujo, Bianca Mendes Souza, Laura Rabelo Leite — 2020
• KRAS gene amplification to define a distinct molecular subgroup of gastroesophageal adenocarcinoma.David Xu, Lindsay Alpert, Peng Xu — 2016
• KRAS gene amplification to define a distinct molecular subgroup of gastroesophageal adenocarcinoma.Les Henderson, Peng Xu, Emily O’Day — 2016
• KRAS amplification and mutation are independent events in gastroesophageal adenocarcinomas (GEA).Russell W. Madison, Joseph Chao, Jeffrey S. Ross — 2019
• KRAS amplification and mutation as independent events in gastroesophageal adenocarcinomas (GEA).Joseph Chao, Russell W. Madison, Jeffrey S. Ross — 2019